Arimidex anastrozole: Marketed to treat post-menopausal hormone-receptor positive breast cancer and advanced breast cancer that has progressed following tamoxif

Researchers published in The Lancet results of a trial in 9,366 patients that showed the disease-free survival at 3

Read the full 193 word article

How to gain access

Continue reading with a
two-week free trial.